List of insiders holdings for T2 Biosystems Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| # | Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| 1 | CR Group L.P. CRG Partners III (Cayman) Lev AIV I L.P. CRG Partners III - Parallel Fund B (Cayman) L.P. CRG Partners III L.P. CRG Partners III - Parallel Fund (A) L.P. CRG Partners III (Cayman) Unlev AIV I L.P. 10% Owner | 2024-05-13 19:21:56 | 10,677,973 0 | 10,677,973 | Form 13D |
| 2 | CANON U.S.A. INC. CANON INC 10% Owner | 2016-09-30 06:07:04 | 6,055,341 0 | 6,055,341 | Form 13D |
| 3 | GOLDMAN SACHS GROUP INC GOLDMAN SACHS & CO Broad Street Principal Investments L.L.C. Bridge Street 2013 Holdings L.P. Bridge Street 2013 Offshore L.P. Bridge Street 2013 L.P. Bridge Street Opportunity Advisors L.L.C. MBD 2013 Holdings L.P. MBD 2013 L.P. MBD 2013 Offshore L.P. 10% Owner | 2021-02-16 15:37:26 | 4,358,868 0 | 4,358,868 | Form 13G |
| 4 | Jones Adrian M Director | 2021-08-03 18:39:33 | 0 4,201,582 | 4,201,582 | Form 4 |
| 5 | GOLDMAN SACHS & CO. LLC GOLDMAN SACHS GROUP INC 10% Owner | 2021-08-03 18:41:31 | 0 4,201,582 | 4,201,582 | Form 4 |
| 6 | CARELLA THOMAS J. Director | 2015-12-11 20:23:48 | 0 4,174,887 | 4,174,887 | Form 4 |
| 7 | MBD Advisors L.L.C. 10% Owner | 2015-12-11 20:22:49 | 0 4,157,240 | 4,157,240 | Form 4 |
| 8 | Polaris Venture Partners V L.P. Polaris Venture Partners Special Founders' Fund V L.P. Polaris Venture Partners Founders' Fund V L.P. Polaris Venture Partners Entrepreneurs' Fund V L.P. Polaris Venture Management Co. V L.L.C. 10% Owner | 2019-02-14 16:04:02 | 1,841,924 0 | 1,841,924 | Form 13D |
| 9 | Sperzel John J III See Remarks | 2025-01-02 18:13:04 | 980,000 0 | 980,000 | Form 4 |
| 10 | Ahuja Aparna Chief Medical Officer | 2022-02-23 18:28:01 | 600,000 0 | 600,000 | Form 4 |
| 11 | McDonough John Director | 2021-07-02 16:00:23 | 516,386 0 | 516,386 | Form 4 |
| 12 | Gibbs Michael Terrence General Counsel | 2025-01-02 18:20:19 | 380,000 0 | 380,000 | Form 4 |
| 13 | Sprague John M CFO | 2025-01-02 18:07:27 | 360,000 0 | 360,000 | Form 4 |
| 14 | Giffin Brett A. Chief Commercial Officer | 2025-01-02 18:55:13 | 360,000 0 | 360,000 | Form 4 |
| 15 | Lowery Thomas J. Chief Scientific Officer | 2020-03-18 16:46:40 | 270,000 0 | 270,000 | Form 4 |
| 16 | Cima Michael J. Director | 2019-06-13 16:31:34 | 213,178 0 | 213,178 | Form 4 |
| 17 | Barclay Alec Chief Operations Officer | 2022-04-11 09:55:54 | 181,945 0 | 181,945 | Form 4 |
| 18 | Jones Marc R. Chief Financial Officer | 2014-08-06 19:21:02 | 166,028 0 | 166,028 | Form 3 |
| 19 | CASTONGUAY MAURICE L Chief Financial Officer | 2015-08-10 11:00:23 | 146,000 0 | 146,000 | Form 4 |
| 20 | Lapidus Stanley Director | 2019-06-13 16:30:36 | 53,010 0 | 53,010 | Form 4 |
| 21 | Lynch Shawn Chief Financial Officer | 2017-02-13 16:41:11 | 52,500 0 | 52,500 | Form 4 |
| 22 | Harding David Chief Commercial Officer | 2017-02-13 16:42:10 | 52,500 0 | 52,500 | Form 4 |
| 23 | Kalil Sarah O. Chief Operating Officer | 2016-01-26 17:21:48 | 40,000 0 | 40,000 | Form 4 |
| 24 | CUMMING JOHN W Director | 2025-01-02 18:28:08 | 35,000 0 | 35,000 | Form 4 |
| 25 | Pare Anthony Chief Commercial Officer | 2021-03-18 16:34:12 | 31,612 0 | 31,612 | Form 4 |
| 26 | Crane Alan L Director | 2014-08-14 16:31:22 | 30,000 0 | 30,000 | Form 4 |
| 27 | Elsbree David B Director | 2025-01-02 18:11:59 | 25,000 0 | 25,000 | Form 4 |
| 28 | Toft Robin Director | 2025-01-02 18:16:26 | 25,000 0 | 25,000 | Form 4 |
| 29 | Saunders Ninfa Director | 2025-01-02 18:18:33 | 25,000 0 | 25,000 | Form 4 |
| 30 | Adams Laura Lee Director | 2025-01-02 18:46:12 | 25,000 0 | 25,000 | Form 4 |
| 31 | LIEBMAN SEYMOUR Director | 2025-01-02 18:58:44 | 25,000 0 | 25,000 | Form 4 |
| 32 | Pfaller Michael A. Chief Medical Officer | 2016-01-26 17:22:50 | 20,000 0 | 20,000 | Form 4 |
| 33 | Bilenker Joshua H. Director | 2016-06-21 14:33:52 | 17,647 0 | 17,647 | Form 4 |
| 34 | WILCOX HARRY W Director | 2016-06-21 14:33:08 | 17,647 0 | 17,647 | Form 4 |
| 35 | LAPIDUS STANLEY N Director | 2015-06-23 16:30:56 | 17,647 0 | 17,647 | Form 4 |
| 36 | Bernard Thierry Director | 2023-10-11 17:00:11 | 7,322 0 | 7,322 | Form 4 |
| 37 | Dhanda Rahul SVP of Corporate Development | 2017-06-08 16:15:16 | 5,667 0 | 5,667 | Form 4 |
| 38 | Spadoro Joanne Chief Operations Officer | 2017-06-08 16:15:16 | 5,589 0 | 5,589 | Form 4 |
| 39 | DEPTULA-HICKS DARLENE M SVP & Chief Financial Officer | 2017-06-08 16:15:00 | 4,000 0 | 4,000 | Form 4 |
| 40 | AISLING CAPITAL III LP Aisling Capital Partners III LP Aisling Capital Partners III LLC ELMS STEVE SCHIFF ANDREW N Purcell Dennis J 10% Owner | 2018-02-07 16:21:21 | 0 0 | 0 | Form 13G |
| 41 | Flagship Ventures Fund 2004 L P Flagship Ventures Fund IV L.P. Flagship Ventures General Partner LLC Flagship Ventures Fund IV General Partner LLC AFEYAN NOUBAR KANIA EDWIN M JR 10% Owner | 2018-02-14 10:52:03 | 0 0 | 0 | Form 13G |